·The Hindu

Deadly span

  • Vultures are nature's carcass-disposal system; their collapse triggers cascading public health costs via feral dog/rabies proliferation — a rare case where a "wildlife" issue has hard economic and epidemiological data attached [S4].
  • India's vulture crisis moved from a chemical threat (diclofenac) to an infrastructure threat (electrocution/collision from expanding power lines) — a shift relevant to environment, energy-infrastructure, and wildlife-law syllabus overlaps [S3].
  • Three Gyps species (white-rumped, Indian/long-billed, slender-billed) are Critically Endangered; India runs a dedicated National Action Plan and captive-breeding programme [S3][S5].

2. Why in the News

  • The Hindu (1 September 2026 edition) reports that electrocution from India's expanding power infrastructure may now rival or supersede NSAID poisoning as the top threat to vultures [S1].
  • A 2025 official survey found vultures nesting at only 50% of their historic nesting sites [S1].
  • Cited 2024 study (American Economic Review) estimating that vulture decline raised human mortality by 4% and cost India $69.4 billion/year via rabies/feral-dog linkages [S1].

3. Background & Evolution

  • 1980s: Vulture population estimated at ~4 crore (40 million) across India [S1].
  • 1990s–2007: Catastrophic 99.5% population crash caused by diclofenac, a veterinary painkiller causing fatal kidney failure (visceral gout) in vultures feeding on treated cattle carcasses [S1][S4].
  • Bombay Natural History Society survey found >90% decline in White-backed, Long-billed and Slender-billed vultures [S4].
  • August 2006: Drugs Controller General of India banned manufacture/sale/use of veterinary diclofenac [S4].
  • 2006: Government of India formulated the National Action Plan on Vulture Conservation (ex-situ + in-situ strategies) [S5].
  • 2008: Gazette notification prohibiting diclofenac manufacture for animal use [S4].
  • 2015: Notification restricting diclofenac packaging to single-dose vials to curb misuse on cattle [S4].
  • 2023: Additional bans extended to other vulture-toxic NSAIDs — aceclofenac and ketoprofen [S1].
  • Vulture Breeding Centres established under MoEFCC/Central Zoo Authority — Pinjore (Haryana) and Rajabhatkhawa (West Bengal) [S5].
  • Emerging threat (2020s): electrocution and collision from expanding transmission/distribution power infrastructure, compounded by unsafe carcass-dumping near installations [S1][S2].

4. Core Static Facts

Item Detail
Species affected White-rumped vulture, Indian (long-billed) vulture, Slender-billed vulture (Gyps genus) — Critically Endangered
Original toxic agent Diclofenac (veterinary NSAID) — causes renal failure/visceral gout [S4]
Additional banned NSAIDs (2023) Aceclofenac, ketoprofen [S1]
Nodal ministry Ministry of Environment, Forest and Climate Change (MoEFCC) [S5]
Key policy instrument National Action Plan on Vulture Conservation, 2006 [S5]
Breeding centres Pinjore (Haryana), Rajabhatkhawa (West Bengal) [S5]
Population fall ~99.5% decline by 2007 from ~4 crore (1980s) [S1]
New threat Electrocution/collision via power transmission/distribution lines [S1][S2]
Nesting site occupancy Only 50% of historic sites occupied per 2025 survey [S1]
Economic cost of decline $69.4 billion/year (2024, American Economic Review study) via rabies-linked mortality [S1]
Human mortality impact +4% rise attributed to vulture decline (feral dog/rabies channel) [S1]

5. Multi-Dimensional Analysis

Environmental

  • Vultures are obligate scavengers; their loss delays carcass removal, disrupting nutrient cycling and disease control [S1].
  • Large wingspan means a single bird can bridge two conductors simultaneously, making them uniquely vulnerable to electrocution compared to smaller birds [S1].
  • Habitat preference for open landscapes and elevated perches directly overlaps with transmission-tower geography [S1].

Social/Public Health

  • Vulture decline → surplus carcasses → increased feral dog populations → rabies outbreaks, directly linking wildlife conservation to human health outcomes [S1][S4].
  • Economic burden ($69.4 billion/year) disproportionately affects rural/agrarian communities near unsafe carcass disposal sites [S1].

Administrative/Governance

  • Multiple ministries involved: MoEFCC (species conservation) vs. Ministry of Power/state DISCOMs (infrastructure) — a coordination gap on retrofitting power lines with bird diverters/insulation [S1][S5].
  • Enforcement of NSAID bans depends on veterinary drug regulation (separate regulatory chain from wildlife protection) [S4].

Scientific/Technological

  • Mitigation demonstrated via carcass-dump relocation away from high-tension infrastructure, reducing collision/electrocution risk without new capital cost [S2].
  • Need for bird-safe insulation, diverters, and spacing standards for new transmission lines in vulture habitats (parallel to Great Indian Bustard powerline litigation) [S1].

Legal/Policy

  • Diclofenac regulated via Drugs Controller General notifications (2006, 2008, 2015) rather than a wildlife statute — an inter-ministerial trap area [S4].
  • No dedicated statutory mandate yet for vulture-safe power infrastructure, unlike the Supreme Court's bustard-related overhead-cable directions.

6. Recent Developments (last 12-18 months)

  • 2025: Official survey reveals vultures nesting at only 50% of historic sites [S1].
  • 2023: Government extended NSAID bans to aceclofenac and ketoprofen, closing loopholes that let toxic alternatives to diclofenac persist [S1].
  • 2024: American Economic Review study quantifies public health/economic cost of vulture decline ($69.4 billion/year, +4% human mortality) [S1].
  • 1 September 2026: The Hindu report highlights electrocution/power-infrastructure risk overtaking chemical threats as the primary emerging concern [S1].

7. Prelims Hooks

  • India's vulture population crashed 99.5% by 2007 from ~4 crore in the 1980s [S1].
  • Diclofenac is a veterinary NSAID that causes fatal visceral gout/kidney failure in vultures [S1][S4].
  • Veterinary diclofenac was banned in August 2006 by the Drugs Controller General of India [S4].
  • 2023 bans extended to aceclofenac and ketoprofen, both NSAIDs toxic to vultures [S1].
  • National Action Plan on Vulture Conservation was formulated in 2006 [S5].
  • Vulture breeding centres: Pinjore (Haryana) and Rajabhatkhawa (West Bengal) [S5].
  • The three most affected species: white-rumped, (Indian) long-billed, and slender-billed vultures — all Gyps genus [S1][S4].
  • Nodal ministry for vulture conservation: MoEFCC, with Central Zoo Authority for breeding programmes [S5].
  • A 2025 survey found vultures nesting at only 50% of historic nesting sites [S1].
  • A 2024 American Economic Review study linked vulture decline to a 4% rise in human mortality and $69.4 billion/year in damages, via feral dog/rabies proliferation [S1].
  • Emerging threat: electrocution from power transmission infrastructure, due to vultures' large wingspans bridging two conductors [S1].
  • Vultures are attracted to power infrastructure areas due to elevated perches, open landscapes, and food waste dumping nearby [S1].

8. Mains Relevance

9. Related Topics to Study Next

  • Great Indian Bustard power-line case (Supreme Court, 2021 & 2024 modification) — parallel precedent on undergrounding/insulating power lines for bird conservation.
  • NSAID regulation and veterinary drug policy — regulatory architecture behind the diclofenac ban.
  • Project Vulture / Species Recovery Programme — broader ex-situ conservation strategy under MoEFCC.
  • Wildlife (Protection) Act, 1972 — legal status/schedule of vulture species.
  • Zoonotic disease and One Health approach — link between wildlife decline and rabies/public health.
  • Renewable energy transmission expansion (green energy corridors) — infrastructure driving new avian mortality risks (also affects Great Indian Bustard).
  • IUCN Red List assessments of Gyps vultures — international conservation status tracking.

10. Common Errors / Trap Areas

  • Confusing diclofenac ban (Drugs Controller General/Health Ministry notification) with a wildlife-law action — it is a pharmaceutical regulation, not a Wildlife Protection Act provision.
  • Assuming all NSAIDs are banned — only diclofenac, aceclofenac, and ketoprofen are restricted; other veterinary painkillers remain unregulated for vulture safety.
  • Mixing up vulture powerline mitigation with the Great Indian Bustard Supreme Court order — they are separate species/cases, though both involve overhead power lines.
  • Misattributing nodal ministry — MoEFCC leads conservation, not Ministry of Power, despite the infrastructure being power-related.
  • Treating the vulture crisis as purely historical — the electrocution threat is a live, escalating (2025-26) concern, not resolved by the diclofenac ban.

11. Sources

  • [S1] Deadly span — India's power infrastructure is emerging as a big threat to vultures, The Hindu, 1 September 2026 — https://www.thehindu.com/todays-paper/2026-09-01/th_chennai/articleGHFGFJQ0Q-16377773.ece — (tier: 4)
  • [S2] Linear power infrastructure and vulture electrocution risk: mitigation through carcass dump relocation in Sudhauwala, Dehradun, India, Journal of Threatened Taxa — https://threatenedtaxa.org/index.php/JoTT/article/view/9501 — (tier: 3)
  • [S3] Tackling Threats, Vulture Conservation Foundation — https://4vultures.org/our-work/tackling-threats/ — (tier: 4)
  • [S4] Government has Taken Steps to Protect Vultures, PIB — https://www.pib.gov.in/newsite/PrintRelease.aspx?relid=133523 — (tier: 1)
  • [S5] Environment Ministry Recommends Ban on Multidose Vial of Diclofenac to Save Vultures, PIB — https://www.pib.gov.in/newsite/PrintRelease.aspx?relid=127003&reg=3&lang=2 — (tier: 1)

Mains Q&A on this note

Also on 1 September

All 1 September articles →